The European Medicines Agency said on Tuesday it had moved forward a meeting to decide on authorisation for the Pfizer-BioNTech vaccine for COVID-19 by more than a week to December 21.
The announcement of a change to the previous date of December 29 came after mounting pressure on the regulator from European countries desperate for a vaccine.
Source: Times of Malta
Updated: 1737
